Literature DB >> 27853159

Interventional cardiology: Absorbing results with degradable stents.

Gregory B Lim.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27853159     DOI： 10.1038/nrcardio.2016.184

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  2 in total

1.  Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.

Authors:  Patrick W Serruys; Bernard Chevalier; Yohei Sotomi; Angel Cequier; Didier Carrié; Jan J Piek; Ad J Van Boven; Marcello Dominici; Dariusz Dudek; Dougal McClean; Steffen Helqvist; Michael Haude; Sebastian Reith; Manuel de Sousa Almeida; Gianluca Campo; Andrés Iñiguez; Manel Sabaté; Stephan Windecker; Yoshinobu Onuma
Journal:  Lancet       Date:  2016-10-30       Impact factor: 79.321

2.  Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial.

Authors:  Clemens von Birgelen; Marlies M Kok; Liefke C van der Heijden; Peter W Danse; Carl E Schotborgh; Martijn Scholte; R Melvyn Tjon Joe Gin; Samer Somi; K G van Houwelingen; M G Stoel; Frits H A F de Man; J Hans W Louwerenburg; Marc Hartmann; Paolo Zocca; Gerard C M Linssen; Job van der Palen; Carine J M Doggen; Marije M Löwik
Journal:  Lancet       Date:  2016-10-30       Impact factor: 79.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.